If you are having trouble viewing this email, view online version .

ESE Daily News Alert - 07 February 2020

Visceral fat increases risk for cognitive decline in adults with diabetes

According to a study published in Clinical Obesity, large amounts of visceral fat may increase risk for cognitive decline in adults with type 2 diabetes.


Diabetes drug may increase risk of cardiovascular complications

According to a study published in The BMJ, Rosiglitazone, a drug used to treat type 2 diabetes, may increase the risk of cardiovascular complications.

Medical News Today

Some oestrogen therapies may reduce heart disease risks

Postmenopausal women using oral conjugated equine oestrogen hormone may have a reduced risk of developing heart disease, according to a study published in Menopause.


The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected